Bouillonamide: A Mixed Polyketide–Peptide Cytotoxin from the Marine Cyanobacterium Moorea bouillonii-Reference-Cited by-同舟云学术

Bouillonamide: A Mixed Polyketide–Peptide Cytotoxin from the Marine Cyanobacterium Moorea bouillonii

Published:2013-08-19 Issue:8 Volume:11 Page:3015-3024
ISSN:1660-3397
Container-title:Marine Drugs
language:en
Short-container-title:Marine Drugs

Author:

Tan Lik,Okino Tatsufumi,Gerwick William

Publisher

MDPI AG

Subject

Drug Discovery,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science

Link

http://www.mdpi.com/1660-3397/11/8/3015/pdf

Reference20 articles.

1. Nitrogen-Containing Metabolites from Marine Cyanobacteria;Gerwick,2001

2. Bioactive natural products from marine cyanobacteria for drug discovery

3. Marine Cyanobacteria: A Treasure Trove of Bioactive Secondary Metabolites for Drug Discovery;Tan,2012

4. Brentuximab Vedotin: A New Age in the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma

5. Marine cyanophyceae of Papua New Guinea. II. Lyngbya bouillonii sp. nov., a remarkable tropical reef-inhabiting blue-green alga;Hoffmann;Belg. J. Bot.,1991

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary metabolites from cyanobacteria: source, chemistry, bioactivities, biosynthesis and total synthesis;Phytochemistry Reviews;2024-04-22

2. Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options;Cancers;2023-04-27

3. Hydrobiological Aspects of Fatty Acids: Unique, Rare, and Unusual Fatty Acids Incorporated into Linear and Cyclic Lipopeptides and Their Biological Activity;Hydrobiology;2022-09-14

4. Exploring Marine as a Rich Source of Bioactive Peptides: Challenges and Opportunities from Marine Pharmacology;Marine Drugs;2022-03-13

5. Harnessing the natural pool of polyketide and non-ribosomal peptide family: A route map towards novel drug development;Current Molecular Pharmacology;2021-03-19